JeffreyFrancisGrynMD

PubMed

• 13 citations
  Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
  John Lister, Jeffrey F. Gryn, Karina L. McQueen, David T. Harris, James M. Rossetti, Richard K. Shadduck> ;Stem Cells and Development. 2007 Feb 1
• 66 citations
  Treatment of acute myelogenous leukemia with outpatient azacitidine
  Nimit Sudan, James M. Rossetti, Richard K. Shadduck, Joan M. Latsko, John A. Lech, Robert B. Kaplan, Margaret Kennedy, Jeffrey Gryn, Yacoub Faroun, John Lister> ;Cancer. 2006 Oct 15
• 39 citations
  Treatment of myelodysplastic syndromes with 5-azacytidine.
  Jeffrey Gryn, Zella R. Zeigler, Richard K. Shadduck, John Lister, Jane M. Raymond, Ibrahim Sbeitan, Charles Srodes, Dennis Meisner, Cynthia Evans> ;Leukemia Research. 2002 Oct 1
• 11 citations
  Factors affecting purification of CD34(+) peripheral blood stem cells using the Baxter Isolex 300i.
  Jeffrey Gryn, Richard K. Shadduck, John Lister, Zella R. Zeigler, Jane M. Raymond> ;Journal of Hematotherapy & Stem Cell Research. 2002 Aug 1
• 93 citations
  Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).
  Z. R. Zeigler, Richard K. Shadduck, Jeffrey F. Gryn, Peter B. Rintels, James N. George, Emmanuel C. Besa, David Bodensteiner, Bernard J. Silver, Robert E Kramer> ;Journal of Clinical Apheresis. 2001 Jan 1
• 19 citations
  Plasminogen activator inhibitor (PAI‐1) antigen levels in primary TTP and secondary TTP post‐bone marrow transplantation
  Maya T. Anthony, Z. R. Zeigler, John Lister, Jane M. Raymond, Richard K. Shadduck, Robert E. Kramer, Jeffrey Gryn, Peter B. Rintels, Emmanuel C. Besa, James N. George,...> ;American Journal of Hematology. 1998 Sep 1
• 41 citations
  Targeted gene conversion in a mammalian CD34+-enriched cell population using a chimeric RNA/DNA oligonucleotide.
  Yufei Xiang, Allyson Cole-Strauss, Kyonggeun Yoon, Jeffrey Gryn, Eric B. Kmiec> ;Journal of Molecular Medicine. 1997 Nov 1
• 52 citations
  Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone...
  Z. R. Zeigler, C. S. Rosenfeld, D. F. Andrews, J. Nemunaitis, Jane M. Raymond, Richard K. Shadduck, R. E. Kramer, Jeffrey Gryn, Peter B. Rintels, Emmanuel C. Besa, Jam...> ;American Journal of Hematology. 1996 Dec 1
• Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide.
  Cole-Strauss, A., Yoon, K., Xiang, Y., Byrne, B. C., Rice, M. C., Gryn, J., Holloman, W. K., Kmiec, E. B.> ;Science. 1996 Sep 6
• The toxicity of daily inhaled amphotericin B.
  Gryn, J., Goldberg, J., Johnson, E., Siegel, J., Inzerillo, J.> ;Am J Clin Oncol. 1993 Feb
• Pentostatin increases the acute toxicity of high dose cyclophosphamide.
  Gryn, J., Gordon, R., Bapat, A., Goldman, N., Goldberg, J.> ;Bone Marrow Transplant. 1993 Sep
• Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: a leukemia intergroup study.
  Goldberg, J., Gryn, J., Raza, A., Bennett, J., Browman, G., Bryant, J., Grunwald, H., Larson, R., Vogler, R., Preisler, H.> ;Am J Hematol. 1993 Aug
• The physiologic effects of inhaled amphotericin B.
  Dubois, J., Bartter, T., Gryn, J., Pratter, M. R.> ;Chest. 1995 Sep
• Detection and monitoring of a concomitant atypical myeloproliferative disorder and chronic lymphocytic leukemia by flow-cytometric immunophenotyping.
  McCoy, J. P., Johnson, E., Catalano, E., Blumstein, L., Overton, W. R., Gryn, J., Donaldson, M. H.> ;Arch Pathol Lab Med. 1995 Nov
• Tretinoin for the treatment of cutaneous graft-versus-host disease.
  Gryn, J., Crilley, P.> ;Bone Marrow Transplant. 1990 Apr
• 2 citations
  High-dose cytosine arabinoside and etoposide in the treatment of relapsed or refractory adult leukemia.
  J Gryn, James F. Conroy, David Topolsky, Pamela Crilley, Kahn Sb, S Bulova, J Weiss, Isadore Brodsky> ;American Journal of Clinical Oncology. 1991 Feb 1
• Emergencies of indwelling venous catheters.
  Gryn, J., Sacchetti, A.> ;Am J Emerg Med. 1992 May
• Propranolol for the treatment of cyclosporine-induced headaches.
  Gryn, J., Goldberg, J., Viner, E.> ;Bone Marrow Transplant. 1992 Mar
• The treatment of relapsed or refractory intermediate grade non-Hodgkin''s lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
  Gryn, J., Johnson, E., Goldman, N., Devereux, L., Grana, G., Hageboutros, A., Fernandez, E., Constantinou, C., Harrer, W., Viner, E., Goldberg, J.> ;Bone Marrow Transplant. 1997 Feb
• Clearance of erythrocyte allo-antibodies using Rituximab.
  Gryn, J., Zeigler, Z. R., Shadduck, R. K., Thomas, C.> ;Bone Marrow Transplant. 2002 Apr
• Join now to see all